Iterum Therapeutics Financial Health

Short Term Liabilities: ITRM's short term assets ($66.7M) exceed its short term liabilities ($7.5M).

Long Term Liabilities: ITRM's short term assets ($66.7M) exceed its long term liabilities ($31.5M).

Debt Level: ITRM has more cash than its total debt.

Reducing Debt: ITRM's debt to equity ratio has increased from 0% to 92.8% over the past 5 years.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: ITRM has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: ITRM has sufficient cash runway for 2.9 years if free cash flow continues to grow at historical rates of 10.8% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.